Skip to main content

Respiratory Syncytial Virus: Babies

Question for Department of Health

UIN 40748, tabled on 15 June 2016

To ask the Secretary of State for Health, pursuant to the Answer of 22 January 2016 to Question 22462, if he will place in the Library a copy of NHS England's report on individual funding requests for palivizumab.

Answered on

28 June 2016

NHS England has advised that it is assessing the effect of individual funding requests for palivizumab on premature babies at risk of severe complications from respiratory syncytial virus. It will report its findings in July 2016.